<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">The high prevalence of diabetes globally makes it a frequent comorbidity in patients with coronavirus-associated disease 2019 (COVID-19). Though diabetes increases the risk of infection in general, most studies have reported prevalence of diabetes almost similar to that in general population in patients with COVID-19. A meta-analysis of eight trials in China showed that diabetes was present in 8% of 46,248 patients with COVID-19 [
 <xref ref-type="bibr" rid="CR1">1</xref>]. Understandably, prevalence of diabetes in patients with COVID-19 varies by region, age and ethnicity. It is not known whether patients with diabetes with well-controlled blood glucose levels have an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS CoV-2).
</p>
